Text Size:AAA

IL-17R / IL-17RA (CD217) 抗體, 兔多抗, 抗原親和純化

產品資料評論實驗方法
描述: Active  
表達宿主: Human Cells  
  • Slide 1
10895-H08H-50
10895-H08H-100
50 µg 
100 µg 
Add to Cart
描述: Active  
表達宿主: Human Cells  
  • Slide 1
10895-H03H-200
10895-H03H-100
200 µg 
100 µg 
Add to Cart
表達宿主: Human Cells  
  • Slide 1
50328-M02H-200
50328-M02H-100
200 µg 
100 µg 
Add to Cart
描述: Active  
表達宿主: Human Cells  
  • Slide 1
50328-M08H-50
50328-M08H-100
50 µg 
100 µg 
Add to Cart
表達宿主: Human Cells  
  • Slide 1
80190-R02H-200
80190-R02H-100
200 µg 
100 µg 
Add to Cart
表達宿主: Human Cells  
  • Slide 1
80190-R08H-200
80190-R08H-100
200 µg 
100 µg 
Add to Cart
表達宿主: Human Cells  
  • Slide 1
90127-C02H-200
90127-C02H-100
200 µg 
100 µg 
Add to Cart

IL17RA/IL-17RA/CD217 AntibodyRelated Products

Related Products

Featured Reagent Products

IL17RA/IL-17RA/CD217 antibody 研究背景

Interleukin-17 receptor (IL-17R), also known as Interleukin-17 receptor A (IL-17RA) and CD217 antigen (CD217), is a cytokine receptor which binds interleukin 17. IL-17R/IL-17RA (CD217) is a proinflammatory cytokine secreted by activated T-lymphocytes. It is a potent inducer of the maturation of CD34-positive hematopoietic precursors into neutrophils. IL-17R/IL-17RA (CD217) is a ubiquitous type I membrane glycoprotein that binds with low affinity to interleukin 17A. Interleukin 17A and its receptor IL-17RA play a pathogenic role in many inflammatory and autoimmune diseases such as rheumatoid arthritis. Like other cytokine receptors, this receptor likely has a multimeric structure. Defects in IL-17R/IL-17RA (CD217) are the cause of familial candidiasis type 5 (CANDF5). CANDF5 is a rare disorder with altered immune responses and impaired clearance of fungal infections, selective against Candida. It is characterized by persistent and/or recurrent infections of the skin, nails and mucous membranes caused by organisms of the genus Candida, mainly Candida albicans.

大鼠 IL17RA/IL-17RA/CD217 antibody 參考資料
  • Gaffen SL. (2009) Structure and signalling in the IL-17 receptor family. Nat Rev Immunol. 9 (8): 556-67.
  • Johansen C, et al.. (2009) Characterization of the interleukin-17 isoforms and receptors in lesional psoriatic skin. Br J Dermatol. 160 (2): 319-24.
  • Yao Z, et al.. (1997) Molecular characterization of the human interleukin (IL)-17 receptor. Cytokine 9 (11): 794-800.
  • 請注意:所有產品都是“僅用於科研,而不能用於診斷或治療用途”